Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Research Paper

Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission

Giuseppe Tringali, Jean Michel Aubry, Katiuscia Moscianese, Claudia Zamori, Mauro Vairano, Paolo Preziosi, Pierluigi Navarra and Giacomo Pozzoli
J Psychiatry Neurosci November 01, 2004 29 (6) 459-466;
Giuseppe Tringali
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Michel Aubry
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katiuscia Moscianese
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Zamori
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Vairano
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Preziosi
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierluigi Navarra
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giacomo Pozzoli
Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 29 no. 6 459-466
PubMed 
15644987
History 
  • Received September 17, 2003
  • Revision received January 7, 2004
  • Accepted January 13, 2004
  • Published online November 1, 2004.
Copyright & Usage 
© 2004 Canadian Medical Association

Author Information

  1. Giuseppe Tringali, PhD,
  2. Jean Michel Aubry, MD,
  3. Katiuscia Moscianese, MD,
  4. Claudia Zamori, PhD,
  5. Mauro Vairano, PhD,
  6. Paolo Preziosi, MD,
  7. Pierluigi Navarra, MD,
  8. Giacomo Pozzoli, MD
  1. Tringali, Zamori, Vairano, Preziosi, Navarra, Pozzoli — Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy; Aubry — Department of Psychiatry, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Moscianese — Department of Psychiatry, Azienda Sanitaria Locale Roma C, Rome, Italy
  1. Correspondence to: Dr. Pierluigi Navarra, Institute of Pharmacology, Catholic University School of Medicine, Largo Francesco Vito 1, 00168 Rome, Italy; fax 39 06233235103; pnavarra{at}rm.unicatt.it
View Full Text

Usage statistics: September 2021 to August 2022

AbstractFullPdf
Sep 2021040
Oct 2021141
Nov 2021310
Dec 2021101
Jan 2022060
Feb 2022052
Mar 2022130
Apr 2022120
May 2022283
Jun 2022183
Jul 202211434
Aug 2022041

Cited By...

  • 19 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 29 (6)
J Psychiatry Neurosci
Vol. 29, Issue 6
1 Nov 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
Giuseppe Tringali, Jean Michel Aubry, Katiuscia Moscianese, Claudia Zamori, Mauro Vairano, Paolo Preziosi, Pierluigi Navarra, Giacomo Pozzoli
J Psychiatry Neurosci Nov 2004, 29 (6) 459-466;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
Giuseppe Tringali, Jean Michel Aubry, Katiuscia Moscianese, Claudia Zamori, Mauro Vairano, Paolo Preziosi, Pierluigi Navarra, Giacomo Pozzoli
J Psychiatry Neurosci Nov 2004, 29 (6) 459-466;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire